Partner Nathan Bear Appointed to Market Advisory Council by the CII for Second Consecutive Year
On January 28, 2021, the Council of Institutional Investors (CII) reappointed Robbins Geller partner Nathan Bear as a member of its Market Advisory Council (MAC). The MAC advises the board of directors and staff on legal, financial reporting, investments, and other trends.
According to the publication, “The primary purpose of [MAC] is to provide input on legal, financial reporting and investment market trends, suggest topics/speakers for upcoming CII meetings and teleconferences, and recommend current and future CII activities that promote and enhance the value of CII membership.”
When asked about his reappointment, Nate said, “I am honored to be reappointed to this incredible team and look forward to our continued efforts advocating for investors.”
Nate is a partner in the Firm’s San Diego office where he has been part of litigation teams that have recovered over $1 billion for investors, including cases In re Cardinal Health, Inc. Sec. Litig. ($600 million) and Jones v. Pfizer Inc. ($400 million). In addition to securities fraud class actions in the United States, Nate has also served as lead counsel in Villella v. Chemical and Mining Company of Chile Inc., a securities class action case against Chilean mining company SQM that resulted in a $62.5 million settlement (preliminarily approved). Nate possesses direct experience in Australian class actions, potential group actions in the United Kingdom, settlements in the European Union, the Dutch Collective Mass Claims Settlement Act, and representative actions in Germany utilizing the Capital Market Investors’ Model Proceeding Act.
Read More Firm News
- “Landmark” $650 Million Settlement in Facebook Biometric Class Action Approved as a “Major Win” for Consumers in the Area of Digital PrivacyFebruary 26, 2021
- February 17, 2021
- Robbins Geller’s Desiree Cummings Appointed to Plaintiffs’ Steering Committee in Blackbaud Data Breach MDLFebruary 17, 2021
- February 8, 2021
- Litigators of the Week: How Robbins Geller Landed a $1.2B Settlement in the Valeant Pharmaceuticals Securities CaseFebruary 5, 2021